Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Mutations of the cyclin‐dependent kinase‐like 5 (<i>CDKL5</i>) gene cause severe neurodevelopmental disorders characterized by intractable epilepsy, intellectual disability, and autism. Multiple mouse models generated for mechanistic studies have exhibited phenotypes similar to some human pathological features, but none of the models has developed one of the major symptoms affecting CDKL5 deficiency disorder (CDD) patients: intractable recurrent seizures. As disrupted neuronal excitation/inhibition balance is closely associated with the activity of glutamatergic and γ‐aminobutyric acidergic (GABAergic) neurons, our aim was to study the effect of the loss of CDKL5 in different types of neurons on epilepsy. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Using the Cre‐LoxP system, we generated conditional knockout (cKO) mouse lines allowing CDKL5 deficiency in glutamatergic or GABAergic neurons. We employed noninvasive video recording and in vivo electrophysiological approaches to study seizure activity in these <i>Cdkl5</i> cKO mice. Furthermore, we conducted Timm staining to confirm a morphological alteration, mossy fiber sprouting, which occurs with limbic epilepsy in both human and mouse brains. Finally, we performed whole‐cell patch clamp in dentate granule cells to investigate cell‐intrinsic properties and synaptic excitatory activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We demonstrate that Emx1‐ or CamK2α‐derived <i>Cdkl5</i> cKO mice manifest high‐frequency spontaneous seizure activities recapitulating the epilepsy of CDD patients, which ultimately led to sudden death in mice. However, <i>Cdkl5</i> deficiency in GABAergic neurons does not generate such seizures. The seizures were accompanied by typical epileptic features including higher amplitude spikes for epileptiform discharges and abnormal hippocampal mossy fiber sprouting. We also found an increase in spontaneous and miniature excitatory postsynaptic current frequencies but no change in amplitudes in the dentate granule cells of Emx1‐cKO mice, indicating enhanced excitatory synaptic activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Significance</h3><p>Our study demonstrates that <i>Cdkl5</i> cKO mice, serving as an animal model to study recurrent spontaneous seizures, have potential value for the pathological study of CDD‐related seizures and for therapeutic innovation. </p></section>

Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder

Autistic-relevant behavioral phenotypes of a mouse model of cyclin-dependent kinase-like 5 deficiency disorder

Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder

In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions

CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures

Searching for biomarkers of CDKL5 disorder: early-onset visual impairment in CDKL5 mutant mice

Longitudinal, multidimensional, observational study of 15 patients with CDKL5 Deficiency Disorder

Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits

Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice

Cell type-specific expression, regulation and compensation of CDKL5 activity in mouse brain

Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder

Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder

Clinical features and gene mutational spectrum of CDKL5 -related diseases in a cohort of Chinese patients

Deletions in the CDKL5 5′ untranslated region lead to CDKL5 deficiency disorder

Novel CDKL5 targets identified in human iPSC-derived neurons

Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology

Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development

Loss of X-linked Protocadherin-19 differentially affects the behavior of heterozygous female and hemizygous male mice

Characterisation of sleep apneas and respiratory circuitry in mice lacking CDKL5

Delineation of Structural Rearrangements as an Overlooked Recurrent Pathological Mechanism

Characterization of Social and Repetitive Behaviors of Mllt11/Af1q/TcF7c Conditional Knockout Mice